Invitation to presentation of Magle Chemoswed’s report for Q1 2022

MFN Publicerad: 05 May 2022 09:30

Today, on 5 May 2022, Magle Chemoswed Holding AB (publ) has published its interim report for Q1 2022.

On Monday 9 May at 11:00 CEST, the company will hold a web conference hosted by CEO Justin Pierce and CFO Petra Jönsson Sjölin. After their presentation, there will be a Q&A session. The conference will be held in English. You can join the conference by computer or mobile device.

The number of participants is limited and we recommend signing up early to secure a spot. Please register at the following link:

https://attendee.gotowebinar.com/register/4349459514924866317

A recording of the web conference will afterwards be available on Magle Chemoswed’s homepage https://maglegroup.com/ and on Västra Hamnen Corporate Finance’s YouTube channel.

About Us

The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes two operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products. Learn more on www.maglechemoswed.com and https://maglegroup.com/ and www.maglepharmacept.com

Västra Hamnen Corporate Finance is the Company's certified advisor on Nasdaq First North Growth Market and can be reached at [email protected] or +46 (0) 40 200 250.

Börskollen

För dig med koll på börsen

Pressmeddelande

Invitation to presentation of Magle Chemoswed’s report for Q1 2022

Bifogade filer

Nyheter om Magle Chemoswed

Läses av andra just nu

Om aktien Magle Chemoswed

Senaste nytt